Evaluation of Sinus Augmentation Bone Healing Using Autograft and Xenograft Compared to Xenograft Alone

January 21, 2026 updated by: Tufts University

Sinus Augmentation Healing With Autogenous and Xenograft Mix Compared to Xenograft Alone

To evaluate bone healing at 4 months after lateral sinus augmentation with a 4:1 ratio of autologous bone and xenograft or xenograft alone. A radiographic volumetric, histomorphometric, and histologic analysis.

Study Overview

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02111
        • Tufts University School of Dental Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients of Tufts School of Dental Medicine (TUSDM)
  • Two stage sinus augmentations with <5mm (Zinner, Small 2004) residual bone height in need of augmentation for implant placement
  • Full maxillary edentulism or Kennedy class I or III
  • 18 to 100 year old

Exclusion Criteria:

  • Adults unable to consent (cognitively impaired adults)
  • Those who self-report as pregnant or breastfeeding
  • Wards of the state
  • Non-Viable neonates
  • Neonates of uncertain viability
  • < 18 years of age
  • Refusal to participate
  • Prior medical condition causing complications in bone metabolism
  • Osteoporosis
  • History of/or current chemotherapy
  • History of/or current head and neck radiation
  • Current heavy smoking > 10 cigarettes/day
  • Self-reported pregnancy or lactation
  • Previous history of sinus elevation procedure
  • Existing sinus pathology or pathology discovered at time of sinus augmentation or implant placement
  • Absence of autogenous donor site

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Xenograft - Autogenous 1:4
Sinus grafted with a ratio of Xenograft - Autogenous 1:4
Randomised Sinus Lift augmentation either with Xenograft - Autogenous ratio 1:4 (test) or Xenograft alone (Control)
An research only use of CBCT at visit 2 to review healing status.
Active Comparator: Xenograft alone
Sinus grafted with Xenograft only
Randomised Sinus Lift augmentation either with Xenograft - Autogenous ratio 1:4 (test) or Xenograft alone (Control)
An research only use of CBCT at visit 2 to review healing status.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Histological analysis
Time Frame: 4 months from surgery
Mineralized and non-mineralized tissue Remnant particles of biomaterial Inflammatory infiltrate
4 months from surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Volumetric bone analysis 4 months post sinus augmentation
Time Frame: 4 months from surgery
Sinus volume calculation via CBCT analysis
4 months from surgery
Radiographic bone height gain at 4 months
Time Frame: 4 months post sinus augmentation
Residual alveolar crest Final alveolar crest height at 4 months Initial height of graft immediately post graft placement Vertical bone material resorption
4 months post sinus augmentation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lorenzo Mordini, DDS, MS, Tufts Univeristy

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2024

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

May 1, 2028

Study Registration Dates

First Submitted

January 30, 2024

First Submitted That Met QC Criteria

January 30, 2024

First Posted (Actual)

February 7, 2024

Study Record Updates

Last Update Posted (Actual)

January 23, 2026

Last Update Submitted That Met QC Criteria

January 21, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00004629

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Implant

Clinical Trials on Sinus Lift augmentation

Subscribe